Assessment of biased agonism at the A
Adenosine
/ analogs & derivatives
Adenosine A3 Receptor Agonists
/ chemical synthesis
Drug Evaluation, Preclinical
/ methods
Flow Cytometry
/ methods
GTP-Binding Protein alpha Subunits
/ genetics
HEK293 Cells
Humans
Ligands
Luminescent Measurements
/ methods
Receptor, Adenosine A3
/ genetics
Signal Transduction
/ drug effects
Structure-Activity Relationship
Transduction, Genetic
/ methods
Transfection
/ methods
beta-Arrestin 2
/ genetics
A(3) adenosine receptor
Biased signaling
G protein-coupled receptor
Structure-activity relationship
β-Arrestin2
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
22
01
2020
accepted:
23
03
2020
pubmed:
1
4
2020
medline:
15
12
2020
entrez:
1
4
2020
Statut:
ppublish
Résumé
The A
Identifiants
pubmed: 32224136
pii: S0006-2952(20)30162-3
doi: 10.1016/j.bcp.2020.113934
pmc: PMC7382964
mid: NIHMS1579843
pii:
doi:
Substances chimiques
ADORA3 protein, human
0
Adenosine A3 Receptor Agonists
0
GTP-Binding Protein alpha Subunits
0
Ligands
0
Receptor, Adenosine A3
0
beta-Arrestin 2
0
Adenosine
K72T3FS567
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
113934Subventions
Organisme : Intramural NIH HHS
ID : Z01 DK031117
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 DK999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DK031117
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Biochem Pharmacol. 2011 Sep 15;82(6):658-68
pubmed: 21718691
Biochem Pharmacol. 2003 May 15;65(10):1675-84
pubmed: 12754103
Bioorg Med Chem Lett. 2016 Jan 15;26(2):241-250
pubmed: 26707396
ACS Chem Biol. 2016 Feb 19;11(2):400-8
pubmed: 26569370
J Biol Chem. 2018 May 11;293(19):7466-7473
pubmed: 29523687
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
Biochem Pharmacol. 2019 Nov;169:113623
pubmed: 31472128
Pharmacol Rev. 2015;67(1):74-102
pubmed: 25387804
Biochem Pharmacol. 2018 Feb;148:298-307
pubmed: 29309765
Nat Rev Drug Discov. 2013 Mar;12(3):205-16
pubmed: 23411724
Anal Chem. 2017 Sep 5;89(17):9527-9536
pubmed: 28771321
PLoS One. 2017 Apr 20;12(4):e0175642
pubmed: 28426733
Bioorg Med Chem. 2004 May 1;12(9):2021-34
pubmed: 15080906
Mol Pharmacol. 2016 Jul;90(1):12-22
pubmed: 27136943
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Mol Pharmacol. 2011 Sep;80(3):367-77
pubmed: 21610196
Biochem Pharmacol. 1986 Aug 1;35(15):2467-81
pubmed: 3017353
J Med Chem. 2007 Mar 22;50(6):1222-30
pubmed: 17309246
Purinergic Signal. 2011 Jun;7(2):171-92
pubmed: 21544511
Biochem Pharmacol. 2018 Dec;158:103-113
pubmed: 30292756
J Med Chem. 2002 Sep 26;45(20):4471-84
pubmed: 12238926
BMC Pharmacol. 2008 Dec 12;8:20
pubmed: 19077268
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):549-77
pubmed: 18253722
Med Res Rev. 2018 Jul;38(4):1031-1072
pubmed: 28682469
Anal Chem. 2016 Dec 6;88(23):11476-11485
pubmed: 27779402
ACS Pharmacol Transl Sci. 2019 Nov 04;3(2):285-295
pubmed: 32296768
Handb Exp Pharmacol. 2009;(193):123-59
pubmed: 19639281
Pharmacol Res. 2008 Apr;57(4):303-11
pubmed: 18424164
Protein Eng Des Sel. 2016 Dec;29(12):583-594
pubmed: 27672048
Br J Pharmacol. 2010 Nov;161(6):1266-75
pubmed: 21049583